[1]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-WO2012/95463,2012,A1
[2]CurrentPatentAssignee:AMGENINC-US2014/213581,2014,A1
[1]CurrentPatentAssignee:ESCAPEBIO-WO2021/7477,2021,A1Locationinpatent:Page/Pagecolumn195
1224431-15-5 | MFZ 10-7 | AA00A0KB | MFCD22683827
1260092-46-3 | Amino-peg1-t-butyl ester | AA00A153 | MFCD20727480
143034-06-4 | SIRT inhibitor 1/2 VII | AA00A1E8 | MFCD00118077
14230-18-3 | 1,2,4-Benzenetris(carboxylic acid ethyl) ester | AA00A3IU | MFCD29039032
141302-40-1 | 4-bromo-1-cyclohexyl-1H-pyrazole | AA00A5RZ | MFCD12824339
1216621-00-9 | 1-(1-(cyclooctylMethyl)-5-(hydroxyMethyl)-1,2,3,6-tetrahydropyridin-4-yl)-3-ethyl-1H-benzo[d]iMidazol-2(3H)-one hydrochloride | AA00A9VX | MFCD09971083
1363378-22-6 | (3R,4S)-4-Amino-1-boc-3-methoxypiperidine | AA00AASO | MFCD22415234
17265-96-2 | PYRIDINE-2,6-D2 | AA00AB37 | MFCD01861559
1779-19-7 | 1,3,6-TRIOXACYCLOOCTANE | AA00ABBS | MFCD00046124
148717-90-2 | Squalamine | AA00ABJ0 | MFCD15146903